As Covid-19 vaccine was being developed, Moderna shelled out more than $1M for top executives' security

As Moderna worked in overdrive to create the second Covid-19 vaccine granted emergency use authorization by the FDA, it spent more than $1.1 million on security for its top executives — the overwhelming majority of which went to keeping CEO Stéphane Bancel safe.